(lp0
S'Sunesis Pharmaceuticals Announces Submission of Responses to the EMA Day 180 ... GlobeNewswire  - 19 hours ago SOUTH SAN FRANCISCO, Calif., March 22, 2017  -- Sunesis Pharmaceuticals, Inc.  today announced that it has submitted its responses to the European Medicine Agency  Day 180 List of Outstanding Issues issued&nbsp;...'
p1
aS"SUNESIS PHARMACEUTICALS, INC.  Files An 8-K Results of Operations ... Market Exclusive - Mar 9, 2017 Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers.Sunesis Pharmaceuticals'  CEO Daniel Swisher on Q4 2016 Results ... - Seeking Alpha"
p2
aS'Sunesis Pharmaceuticals updates on SNS-062 and Vosaroxin programs Seeking Alpha - Jan 23, 2017 Sunesis Pharmaceuticals  announces clinical and regulatory updates to its two lead programs, SNS-062, a second-generation reversible and non-covalent BTK inhibitor, and vosaroxin, an anti-cancer quinolone derivative currently under review ...'
p3
aS'Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and ... GlobeNewswire  - Jul 29, 2016 SOUTH SAN FRANCISCO, Calif., July 29, 2016  -- Sunesis Pharmaceuticals, Inc.  today reported financial results for the second quarter ended June 30, 2016.Cowen Comments on Sunesis Pharmaceuticals, Inc.  Following 2Q:16 Update - Smarter Analyst'
p4
aS'BRIEF-Sunesis Pharmaceuticals provides update on EU marketing app for vosaroxin Reuters - 19 hours ago March 22 Kinder Morgan Inc said it had booked all of the 22,000 barrels per day of capacity it had offered to the oil industry on its Canadian Trans Mountain pipeline expansion project earlier this month, following a dip in shipper commitments.'
p5
aS"Sunesis Pharmaceuticals Announces Poster Presentation on Preliminary Results ... GlobeNewswire  - Sep 1, 2016 SOUTH SAN FRANCISCO, Calif., Sept. 01, 2016  -- Sunesis Pharmaceuticals, Inc.  today announced that a poster detailing preliminary results from the Company's Phase 1A study in healthy volunteers evaluating oral&nbsp;..."
p6
aS'Sunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split GlobeNewswire  - Sep 7, 2016 SOUTH SAN FRANCISCO, Calif., Sept. 07, 2016  -- Sunesis Pharmaceuticals, Inc.  today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-6&nbsp;...'
p7
aS'Sunesis Pharmaceuticals Inc.: Sunesis Pharmaceuticals to Present at the 19th ... The Wall Street Transcript - Feb 6, 2017 06, 2017  -- Sunesis Pharmaceuticals, Inc.  today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at the 19 Annual BIO CEO &amp; Investor Conference on Monday, February 13 at 5:30 PM&nbsp;...'
p8
aS'Does Sunesis Pharmaceuticals, Inc.  Have Sufficient Cash To ... Scibility Media - Aug 1, 2016 Sunesis Pharmaceuticals, Inc.  continues to lose money as its latest financial results for 2Q2016 and 1H2016 show.'
p9
aS'The Zacks Investment Research Lowers Sunesis Pharmaceuticals, Inc.  to Hold Petro Global News 24 - Mar 21, 2017 Zacks Investment Research downgraded shares of Sunesis Pharmaceuticals, Inc.  from a buy rating to a hold rating in a report issued on Wednesday morning.'
p10
a.